Category Archives: Fosamax

Featured Stories

FDA Metal-On-Metal Hip Replacement Investigation Is Flawed, Researchers Say

The U.S. Food & Drug Administration’s (FDA) metal-on-metal hip replacement investigation is flawed, according to researchers.

Read More

Colorado Woman Sues American Medical Systems Over Transvaginal Mesh Injuries

Parker Waichman LLP, a national law firm, just filed a lawsuit on behalf of a Colorado woman allegedly injured by transvaginal mesh products manufactured by American Medical Systems, Inc. The suit was filed on May 21, 2012 in the U.S. District Court for the Northern District of California (Case No. ...

Read More

Do Vitamin Drinks Pose Health Risks?Do Vitamin Drinks Pose Health Risks?

Do Vitamin Drinks Pose Health Risks?

Scientists are concerned vitamin drinks are contributing to levels of vitamins and other nutrients that are not only unnecessary, but potentially harmful.

Read More

Zadroga Act Cancer Decision Expected This Week

The federal official tasked with determining what ailments should be covered by the federal Zadroga Act is expected to decide by Saturday if certain cancers will be eligible for compensation. The decision is being eagerly awaited by thousands of first responders who believe they developed cancer due to exposure ...

Read More

Medtronic Sprint Fidelis Leads Vulnerable to Fracture after ICD Switch

Medtronic Sprint Fidelis leads are vulnerable to fracture following ICD switch, says a new study published in the June issue of the journal Heart Rhythm.

Read More

Decision on Pradaxa Bleeding Lawsuit Multidistrict Litigation Expected Soon

Victims of alleged Pradaxa injuries are awaiting word on whether their lawsuits will be consolidated in a multidistrict litigation. According to a report from The Madison Record, so far just over two dozen Pradaxa bleeding lawsuits have been filed in federal courts throughout the U.S.

Read More

Medtronic Infuse Studies Faulted for Downplaying Side Effects

Medtronic Inc.’s published studies for its Infuse bone graft product may have downplayed serious side effects, according to an analysis published last year in The Spine Journal. The study, which drew on U.S. Food & Drug Administration (FDA) documents and other data sources, suggests that up to half of ...

Read More

National Law Firms Calls for More FDA Action on Actos Bladder Cancer Threat

A national law firm is not satisfied with the way the U.S. Food & Drug Administration (FDA) has handled warnings regarding Actos (pioglitazone) bladder cancer risks. In a statement published today, Parker Waichman LLP called on the FDA to compel Takeda Pharmaceuticals, the maker of the type 2 diabetes drug, ...

Read More

Transvaginal Mesh Lawsuit Trial

$5.5 Million Awarded to Plaintiffs in First Transvaginal Mesh Lawsuit Trial

An award of $5.5 million has been made in the first trial over a transvaginal mesh lawsuit. The jury found against medical device maker, C.R. Bard, and its Avaulta Plus transvaginal mesh. The jury agreed that Bard’s Avaulta Plus transvaginal mesh caused numerous and painful injuries in a California woman. ...

Read More

Bisphosphonates Associated with Increased Risk of Atypical Hip Fractures, Researcher Says

The use of bisphosphonates, drugs prescribed to prevent hip fractures in women with osteoporosis, is associated with an increased risk of atypical fractures in this joint. The research is contained in a PhD thesis by Javier Gorricho-Mendívil, at the NUP/UPNA-Public … Continue reading

Posted in Bisphosphonates, Fosamax, Health Concerns, Pharmaceuticals |

Judge Delays Fosamax MDL “Wind-Down”

judge_delays_fosamax_lawsuit

To enable plaintiffs and Merck &  Co. Inc. time to work on a potential settlement, a New York federal judge delayed the transfer of hundreds of lawsuits that are part of a multidistrict litigation (MDL) brought over alleged jaw injuries … Continue reading

Posted in Fosamax, Pharmaceuticals |

Merck Cutting Staff Over Research Unit Re-Structure Plans

merck_cutting_staff

Drug giant, Merck, has announced plans to cut 8,500 employees as part of a restructuring meant to increase marketplace competitiveness. Over the next two years, in addition to the massive layoffs, Merck also announced that it would be implementing significant … Continue reading

Posted in Defective Medical Devices, Fosamax, Medtronic Infuse, Pharmaceuticals |

Hundreds of Fosamax Lawsuits Being Sent to Trial

fosamax_lawsuits_go_through

A federal judge just ordered hundreds of cases involved in a multidistrict litigation (MDL) brought against Merck & Co. over alleged Fosamax jaw injuries be sent for trial in courts nationwide. Fosamax is Merck’s osteoporosis medication. Drug and device manufacturers … Continue reading

Posted in Fosamax, Pharmaceuticals |

Judge Denies Merck’s Request to Force Fosamax Plaintiffs To Verify Injuries

judge_denies_merck_fosamax_verification

This week, a New York federal judge denied a request to mandate hundreds of alleged Fosamax victims to substantiate their injuries. Fosamax is manufactured by Merck & Co. U.S. District Judge John Keenan refused the request that would not only … Continue reading

Posted in Fosamax, Pharmaceuticals |

Bisphosphonate Use Linked to Barrett’s Esophagus

bisphonates_linked_tp_barrets_esophagus

A study published last month in the American Journal of Gastroenterology suggests that oral bisphosphonate use was associated with a 2.33 percent increased risk of Barretts’ esophagus, a condition that increases the risk of developing esophageal cancer. Barrett’s esophagus, a … Continue reading

Posted in Fosamax, Health Concerns, Pharmaceuticals |

Judge Overrules Merck’s Bid to Boot Expert Testimony from Four Doctors in Fosamax Trial

Merck and Co. was unable to stop doctors from giving expert testimony during the New Jersey-based trial, now under way, regarding osteoporosis drug Fosamax for allegedly causing atypical femur fractures. The federal judge ruled, however, that while the plaintiff’s treating … Continue reading

Posted in Fosamax, Legal News, Pharmaceuticals |

Opening Statements Heard in Second Fosamax Femur Fracture Trial

The second Fosamax femur fracture trial is underway and involve allegations that Merck’s Fosamax (alendronate) caused femur fractures in some people. The trial began in New Jersey federal court and opening statements are being heard. The lawsuit is one of … Continue reading

Posted in Fosamax, Pharmaceuticals |

Fosamax Lawsuit Begins with Opening Remarks

Opening arguments today signaled the start of the second trial charging Merck’s Fosamax with causing femur fractures. In New Jersey federal court the focus was on the case of 58-year-old Bernadette Glynn, who says that the osteoporosis drug is part … Continue reading

Posted in Fosamax |

Second Fosamax Femur Injury Trial Underway

Merck & Company, the maker of Fosamax (alendronate), is facing a second of thousands of cases brought by plaintiffs who allege they suffered Fosamax injuries. The first lawsuit recently ended in a mistrial unrelated to the injury allegations. The plaintiff … Continue reading

Posted in Fosamax, Pharmaceuticals |

© 2005-2017 Parker Waichman LLP ®. All Rights Reserved.